Novo Nordisk A/S ADR
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$47.94avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Novo Nordisk A/S ADR in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Asset Planning,Inc ($247K).
- Company
- Novo Nordisk A/S ADR
- CUSIP
- K7314N152
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 100 shares sold, net −100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Asset Planning,Inc | 0.16% | Reduce -1.9% | 5,150 | $247K |
"% of holder's portfolio" is Novo Nordisk A/S ADR's weight in each manager's 13F, not the share of Novo Nordisk A/S ADR the manager owns.